A prospective study on prevalence and treatment pattern of benign prostate hyperplasia at a tertiary care hospital
Abstract
The most prevalent urological issue among elderly men is benign prostatic hyperplasia (BPH), which is becoming more and more widespread globally.To assess LUTS owing to BPH, the international Prostate symptom score (IPSS) is a helpful and validate questionnaire.Treatment for BPH is based on the severity of symptoms and seeks to reduce progression risk, enhance quality of life, and improve symptoms.To study the prevalence and treatment Objective: pattern of BPH.A hospital based prospective observational study was carried out over a period of nine Methodology: months at the urology department of St. Philomena's Hospital, Bangalore.A total of 80 patients were enrolled Results: and majority were in the age group of 60-70 years.According to IPSS scoring, maximum patients had Mild symptoms.The incidence rate of LUTS among BPH patients was found to 100%.Majority of the patients were treated with combination of tamsulosin and dutasteride followed by tamsulosin alone.2.5% patients developed adverse drug reactions and which was found to be Erectile dysfunction induced by tamsulosin and alfuzosin.It was found that the relationship between age and QoL and IPSS is statistically insignificant.Here by I conclude the study by Conclusion: stating that BPH was managed with combination of tamsulosin and dutasteride followed by tamsulosin alone.Majority of patients quality of life was found to be dissatisfied.So, a counselling from clinical pharmacist would help them to improve their quality of…
Read the paper
Related studies
- Luteolin rescues postmenopausal osteoporosis elicited by OVX through alleviating osteoblast pyroptosis via activating PI3K-AKT signaling
- Drugs Used in “Chemsex”/Sexualized Drug Behaviour—Overview of the Related Clinical Psychopharmacological Issues
- Luteolin Inhibits Dexamethasone‐Induced Osteoporosis by Autophagy Activation Through miR‐125b‐5p/SIRT3/AMPK/mTOR Axis, an In Vitro and In Vivo Study
- Cutting-edge insights into liver fibrosis: advanced therapeutic strategies and future perspectives using engineered mesenchymal stem cell-derived exosomes
- Can we predict and manage persistent storage and voiding LUTS following bladder outflow resistance reduction surgery in men? ICI‐RS 2023
- Chylomicron-mimicking supramolecular nano emulsion for oral luteolin delivery against hyperuricemia
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.